ESC Congress is the place where cardiologists and researchers of all stages of their career, join forces with colleagues, peers, and their cardiology heroes, to share invaluable data and learn. 

Join the discussions in this group to discuss cardiology cases and discuss your insights around key developments in Cardiology.

The ESC Congress 2024 London takes place from 30 Aug - 2 September 2024 both onsite & online. Programme: https://esc365.escardio.org/ESC-Congress

ESC Congress 2024

Latest presentations from ESC Heart Failure 2022

MedShr Editor

Late Breaking Clinical Trial - Presented at #ESC HF 2022

Use of Remote Speech Analysis to Predict Worsening Heart Failure Events in Ambulatory Heart Failure Patients

Late Breaking Clinical Trial - Presented at #ESC Heart Failure 2022

Cardiac Contractility Modulation Therapy Improves Health Status in Patients with Heart Failure with Preserved Ejection Fraction

Ghrelin-HF: intravenous ghrelin in heart  failure with reduced ejection fraction

Prognostic impact of the updated 2018 HFA-ESC definition of advanced HF: Results from the HELP-HF Registry

SIRONA 2: Primary safety and efficacy endpoints evaluating the CordellaTMPA Sensor System in NHYA Class III HF patients

No-implant interatrial shunt for heart failure with preserved ejection fraction: Preliminary multi-centre clinical outcomes from ALLEVIATE-HF1 and HF-2

Finerenone in chronic kidney disease and type 2 diabetes: A FIDELITY analysis of left ventricle hypertrophy

Design and Baseline Characteristics of the DELIVER Trial

REVEAL-CKD: diagnosis and management of stage 3 chronic kidney disease in patients with heart failure in Italy

Metabolomic Profiling of the Effects of Dapagliflozin in Heart Failure with Reduced Ejection Fraction: DEFINE-HF

Phase 2, Randomized, Double-Blind, Placebo-Controlled, Safety and Efficacy Study of Dutogliptin in Combination with Filgrastim in Early Recovery Post-Myocardial Infarction